Mutations in subunits of the epithelial sodium channel cause salt wasting with hyperkalaemic acidosis, pseudohypoaldosteronism type 1
The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
Autosomal recessive pseudohypoaldosteronism type I is a rare life-threatening disease characterized by severe neonatal salt wasting, hyperkalaemia, metabolic acidosis, and unresponsiveness to mineralocorticoid hormones. Investigation of affected offspring of consanguineous union reveals mutations in either the alpha or beta subunits of the amiloride-sensitive epithelial sodium channel in five kindreds. These mutations are homozygous in affected subjects, co-segregate with the disease, and introduce frameshift, premature termination or missense mutations that result in loss of channel activity. These findings demonstrate the molecular basis and explain the pathophysiology of this disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Gainof-function mutations due to carboxy-terminal truncation of -ENaC cause Liddle's syndrome, an autosomal dominant form of salt-retaining hypertension (640).”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [640]
In the citing paper
“The more common autosomal recessive form of PHA (pseudohypoaldosteronism type II) is caused by inactivating mutations in any of the three subunits (␣, , and ␥) of the amiloridesensitive epithelial sodium channel (ENaC) (640).”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [640]
Citations
Cites
Amiloride-sensitive epithelial Na+ channel is made of three homologous subunits
Canessa, C. M., Schild, L., Buell, G., Thorens, B., Gautschi, I., Horisberger, J.-D., & Rossier, B. C. (1994) · Nature · doi:10.1038/367463a0 · Cited by 1,961
Self-citationThe 1993–94 Généthon human genetic linkage map
Gyapay, G., Morissette, J., Vignal, A., Dib, C., Fizames, C., Millasseau, P., Marc, S., Bernardi, G., Lathrop, M., & Weissenbach, J. (1994) · Nature Genetics · doi:10.1038/ng0694supp-246 · Cited by 1,835
The Kidney: Physiology and Pathophysiology
(1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-6-544_3 · Cited by 1,673
Shimkets, R. A., Warnock, D. G., Bositis, C. M., Nelson-Williams, C., Hansson, J. H., Schambelan, M., Gill, J. R., Ulick, S., Milora, R. V., Findling, J. W., et al. (1994) · Cell · doi:10.1016/0092-8674(94)90250-x · Cited by 1,259
Self-citationSimon, D. B., Nelson-Williams, C., Johnson Bia, M., Ellison, D., Karet, F. E., Morey Molina, A., Vaara, I., Iwata, F., Cushner, H. M., Koolen, M., et al. (1996) · Nature Genetics · doi:10.1038/ng0196-24 · Cited by 1,219
Self-citationEpithelial sodium channel related to proteins involved in neurodegeneration
Canessa, C. M., Horisberger, J.-D., & Rossier, B. C. (1993) · Nature · doi:10.1038/361467a0 · Cited by 920
Self-citationPolymorphic DNA region adjacent to the 5' end of the human insulin gene.
Bell, G. I., Karam, J. H., & Rutter, W. J. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.9.5759 · Cited by 889
Early death due to defective neonatal lung liquid clearance in αENaC-deficient mice
Hummler, E., Barker, P., Gatzy, J., Beermann, F., Verdumo, C., Schmidt, A., Boucher, R., & Rossier, B. C. (1996) · Nature Genetics · doi:10.1038/ng0396-325 · Cited by 876
Self-citationHomozygosity Mapping: A Way to Map Human Recessive Traits with the DNA of Inbred Children
Lander, E. S., & Botstein, D. (1987) · Science · doi:10.1126/science.2884728 · Cited by 875
Hansson, J. H., Nelson-Williams, C., Suzuki, H., Schild, L., Shimkets, R., Lu, Y., Canessa, C., Iwasaki, T., Rossier, B., & Lifton, R. P. (1995) · Nature Genetics · doi:10.1038/ng0995-76 · Cited by 754
Self-citation
Research works printed but not linked: 1
- McDonald, F.J., Snyder, P.M., McCaray, P.B. Jr. & Welsh, M.J. Cloning, expression, and tissue distrubution of a human amiloride-sensitive Na+ channel. Am. J. Physiol. 268, L728–734 (1994).
Cited by
Items 501–600 of 801
Bandhakavi, M., Wanaguru, A., Ayuk, L., Kirk, J. M. W., Barrett, T. G., Kershaw, M., Högler, W., & Shaw, N. J. (2021) · European Journal of Endocrinology · doi:10.1530/eje-20-0152 · Cited by 12
In Vivo and Ex Vivo Analysis of Tubule Function
Stockand, J. D., Vallon, V., & Ortiz, P. A. (2012) · Comprehensive physiology · doi:10.1002/cphy.c100051 · Cited by 14
Identification of NPC2 protein as interaction molecule with C2 domain of human Nedd4L
Araki, N., Ishigami, T., Ushio, H., Minegishi, S., Umemura, M., Miyagi, Y., Aoki, I., Morinaga, H., Tamura, K., Toya, Y., et al. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.07.158 · Cited by 12
Genetic testing for renal diseases: Medical and ethical considerations
Marsick, R., Limwongse, C., & Kodish, E. D. (1998) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(98)70087-3 · Cited by 12
PPAR γ Agonists: Blood Pressure and Edema
Blazer‐Yost, B. L. (2009) · PPAR Research · doi:10.1155/2010/785369 · Cited by 13
“In loss-of-function mutations, life-threatening salt wasting, hypotension, and hyperkalemia occur during the neonatal period [32, 33].”
BackgroundHanukoglu, A., Belutserkovsky, O., & Phillip, M. (2001) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(01)00028-0 · Cited by 12
Self-citationDing, Y. P., Cui, Y., Zhou, Z., Hou, Y., Pang, X., & Nie, H. (2020) · BioMed Research International · doi:10.1155/2020/8150780 · Cited by 11
“Among αβc-ENaC subunits, the α-subunit is believed to form electrically detectable Na-selective channels, whereas the βand c-subunits serve as accessory regulatory subunits that can increase, by two orders of magnitude, the amplitude of channel activity from the α-subunit alone [16, 28, 29].”
BackgroundThe use of sodium resonium in pseudohypoaldosteronism
Porter, J. R. (2003) · Archives of Disease in Childhood · doi:10.1136/adc.88.12.1138-b · Cited by 11
Puttini, S., Beggah, A., Ouvrard‐Pascaud, A., Legris, C., Blot‐Chabaud, M., Farman, N., & Jaisser, F. (2001) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.0360.2000 · Cited by 11
“Pseudohypoaldosteronism has been linked to mutations of ENaC subunits (4), autosomal dominant distal renal tubular acidosis is associated with mutations of AE1 (19), whereas Bartter’s syndrome has been related to mutations in the genes encoding for the Na(1)-K(1)2Cl(2) transporter, the ROMK potassium channel, or the C…”
Otulakowski, G., Freywald, T., Wen, Y., & O'Brodovich, H. M. (2001) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.2001.281.5.l1219 · Cited by 15
“It thus plays a major role in the regulation of salt homeostasis and blood pressure as indicated by the existence of genetic hypertensive and hypotensive diseases associated with ENaC gene mutations, such as Liddle’s syndrome (45) and pseudohypoaldosteronism type 1 (5).”
BackgroundInherited Disorders of Renal Salt Homeostasis
Scholl, U. I., & Lifton, R. P. (2013) · Seldin and Giebisch's The Kidney · doi:10.1016/b978-0-12-381462-3.00036-7 · Cited by 10
Self-citationAutosomal dominant pseudohypoaldosteronism type 1 with a novel splice site mutation in MRgene
Kanda, K., Nozu, K., Yokoyama, N., Morioka, I., Miwa, A., Hashimura, Y., Kaito, H., Iijima, K., & Matsuo, M. (2009) · BMC Nephrology · doi:10.1186/1471-2369-10-37 · Cited by 10
“Recently, it became clear that mutations in the MR gene (MR or NR3C2) leads to autosomal dominant renal PHA1 and mutations in the ENaC alpha, beta and gamma subunit genes (SCNN1A, SCNN1B and SCNN1G) leads to autosomal recessive severe systemic PHA1 [3,4].”
BackgroundInherited Disorders of Sodium and Water Handling
Gross, P. A., & Heduschka, P. (2010) · Elsevier eBooks · doi:10.1016/b978-0-323-05876-6.00047-2 · Cited by 11
Küçükali, G. K., Çetinkaya, S. Ç., Tunç, G., Oğuz, M. M., Çelik, N., Akkaş, K. Y., Şenel, S., Lafcı, N. G., & Erdeve, Ş. S. (2020) · Journal of Clinical Research in Pediatric Endocrinology · doi:10.4274/jcrpe.galenos.2020.2020.0107 · Cited by 11
“Plasma aldosterone concentration stated as 1 g/L (1-95) in the article.”
BackgroundPlasma membrane insertion of epithelial sodium channels occurs with dual kinetics
González‐Montelongo, R., Barros, F., de la Rosa, D. Á., & Giráldez, T. (2016) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-016-1799-4 · Cited by 11
Disorders of Potassium Balance
Goilav, B., & Trachtman, H. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-225-4_3 · Cited by 10
Sodium Chloride Transport in the Loop of Henle, Distal Convoluted Tubule, and Collecting Duct
Gamba, G., Wang, W., & Schild, L. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-381462-3.00034-3 · Cited by 11
Self-citationVantyghem, M., Perimenis, P., & Wémeau, J.-L. (2004) · La Presse Médicale · doi:10.1016/s0755-4982(04)98501-6 · Cited by 11
Hendron, E., Patel, P. Y., Hausenfluke, M., Gamper, N. L., Shapiro, M. S., Booth, R. E., & Stockand, J. D. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204615200 · Cited by 10
Sodium Chloride Transport in the Loop of Henle, Distal Convoluted Tubule, and Collecting Duct
Reeves, W. B., & Andreoli, T. E. (2008) · Elsevier eBooks · doi:10.1016/b978-012088488-9.50034-6 · Cited by 10
Activation of autosomal recessive Pseudohypoaldosteronism1 ENaC with aldosterone
Shabbir, W., Topcagic, N., & Aufy, M. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.174090 · Cited by 9
Mineralocorticoid Action in the Aldosterone Sensitive Distal Nephron
Staub, O., & Loffing, J. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-381462-3.00035-5 · Cited by 11
The Physiome Project, open EHR Archetypes, and the Digital Patient
Nickerson, D. P., Atalağ, K., de Bono, B., & Hunter, P. J. (2016) · Wiley eBooks · doi:10.1002/9781118952788.ch9 · Cited by 9
Knoepp, F., Bettmer, J., & Fronius, M. (2017) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2017.02.019 · Cited by 9
Lucarelli, M., Pierandrei, S., Maria, S., & Ström, R. (2012) · InTech eBooks · doi:10.5772/30281 · Cited by 9
“Interestingly, some PHA-I patients, without CFTR mutations, also exhibit CF-like lung symptoms, such as recurrent bacterial infection of the airways (Hanukoglu et al., 1994).”
BackgroundInfluentialIon Channels in Digestive Health and Disease
Feranchak, A. P. (2003) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/00005176-200309000-00006 · Cited by 11
“Mutations in ENaC produce several diseases of blood pressure regulation including Liddle’s syndrome (50) and pseudohypoaldosteronism type-1 (51).”
BackgroundMueller, G. M., Yan, W., Copelovitch, L. A., Jarman, S., Wang, Z., Kinlough, C. L., Tolino, M. A., Hughey, R. P., Kleyman, T. R., & Rubenstein, R. C. (2012) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00493.2011 · Cited by 10
Context-dependent mechanisms modulating aldosterone signaling in the kidney
Shibata, S. (2016) · Clinical and Experimental Nephrology · doi:10.1007/s10157-016-1232-5 · Cited by 10
Loh, S. Y., Giribabu, N., & Salleh, N. (2017) · Steroids · doi:10.1016/j.steroids.2017.09.008 · Cited by 10
“In contrast, enhanced ENaC subunits’ activity can cause severe hypertension [14,15].”
Renal Tubular Disorders of Electrolyte Regulation in Children
Devuyst, O., Belge, H., Konrad, M., Jeunemaître, X., & Zennaro, M. (2015) · Springer eBooks · doi:10.1007/978-3-662-43596-0_34 · Cited by 10
Quigley, R. P. (2009) · Springer eBooks · doi:10.1007/978-3-540-76341-3_39 · Cited by 9
Interaction of Modeling and Experimental Approaches to Understanding Renal Salt and Water Balance
Schafer, J. A. (2000) · Annals of Biomedical Engineering · doi:10.1114/1.1308497 · Cited by 9
Genetic Determinants of Blood Pressure Regulation
Ambler, S. K., & Brown, R. D. (1999) · The Journal of Cardiovascular Nursing · doi:10.1097/00005082-199907000-00007 · Cited by 12
Normal CFTR Activity and Reversed Skin Potentials in Pseudohypoaldosteronism
Reddy, M. M., Wang, X. F., Gottschalk, M. E., Jones, K. A., & Quinton, P. M. (2005) · The Journal of Membrane Biology · doi:10.1007/s00232-005-0740-0 · Cited by 9
“The autosomal recessive PHA-1 is caused by loss-offunction mutations in ENaC [5, 7, 8, 11, 27, 29].”
BackgroundRegulating distal nephron functions and salt sensitivity
Ueda, K., & Shimosawa, T. (2024) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00103.2024 · Cited by 8
Risk Factors and Management of Transient Tachypnea of the Newborn
Guglani, L., Ryan, R. M., & Lakshminrusimha, S. (2009) · Pediatric Health · doi:10.2217/phe.09.24 · Cited by 8
Gaukrodger, N., Avery, P. J., & Keavney, B. D. (2008) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00732.2007 · Cited by 8
“(Chang et al. 1996) A number of groups have investigated the role of common polymorphisms in the genes encoding the ENaC subunits as potential susceptibility alleles influencing the risk of essential hypertension to a moderate degree.”
BackgroundUnique eyelid manifestations in type 1 pseudohypoaldosteronism
Nasir, A. K., & Najab, I. A. (2012) · Archives of Disease in Childhood Fetal & Neonatal · doi:10.1136/archdischild-2011-301339 · Cited by 8
Failure to Thrive, Hyponatremia, and Hyperkalemia in a Neonate
Sopfe, J., & Simmons, J. H. (2013) · Pediatric Annals · doi:10.3928/00904481-20130426-09 · Cited by 10
A flexible GAS belt responds to pore mutations changing the ion selectivity of proton-gated channels
Chen, Z., Lin, S., Xie, T., Lin, J., & Canessa, C. M. (2021) · The Journal of General Physiology · doi:10.1085/jgp.202112978 · Cited by 8
Böckenhauer, D., Lopez-Garcia, S. C., & Walsh, S. B. (2022) · Springer eBooks · doi:10.1007/978-3-030-52719-8_111 · Cited by 8
Oh, Y. S., Saxena, S., & Warnock, D. G. (1999) · Journal of Clinical Investigation · doi:10.1172/jci8378 · Cited by 8
Transient Pseudohypoaldosteronism with Complex Malformation of Internal Genitalia
Iliev, D. I., Petruch, U. R., Ranke, M., Binder, G., Leriche, C., Strotbek, G., & Wollmann, H. A. (2000) · Hormone Research in Paediatrics · doi:10.1159/000053249 · Cited by 8
Rodríguez‐Soriano, J., & Vallo, A. (1997) · Pediatric Nephrology · doi:10.1007/s004670050339 · Cited by 8
“Pseudohypoaldosteronism type 1 was easily ruled out since in this condition the renal sodium loss is always associated with hyperkalemia and metabolic acidosis [6, 7].”
BackgroundNicolaides, N. C., & Chrousos, G. P. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813814-4.00028-6 · Cited by 9
Xu, P., Sudarikova, A. V., Ilatovskaya, D. V., Gildea, J. J., Akhter, M., Carey, R. M., Yue, W., José, P. A., & Felder, R. A. (2022) · Biomedicines · doi:10.3390/biomedicines10050981 · Cited by 8
Zheng, K., & Layton, A. T. (2024) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00398.2023 · Cited by 8
O'Connell, S. M., Johnson, S. R., Lewis, B. D., Staltari, L., Peverall, J., Ly, T. T., Martin, A. C., Jones, T. W., Price, G. J., Murch, A. R., et al. (2011) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.2011.230 · Cited by 7
“23) of the inversion probably results in haplo-insuffi ciency of MR as observed for the mutants insT1354 and del8bp537 (3) , which lack transcriptional activity.”
BackgroundResistência aos mineralocorticóides: pseudo-hipoaldosteronismo tipo 1
Fernandes-Rosa, F. L., & Antonini, S. R. R. (2007) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302007000300004 · Cited by 11
Regulation of epithelial Na channels by aldosterone
Palmer, L. G., & Frindt, G. (2016) · Kitasato medical journal · Cited by 7
Clinical Syndromes of Metabolic Acidosis
Krapf, R., Seldin, D. W., & Alpern, R. J. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-381462-3.00059-8 · Cited by 7
Miliaire rouge et pseudo hypoaldostéronémisme de type 1b de révélation néonatale
Argoubi, H., Fitchner, C., Richard, O., Lavocat, M.-P., Cambazard, F., & Stéphan, J.-L. (2007) · Annales de Dermatologie et de Vénéréologie · doi:10.1016/s0151-9638(07)91819-0 · Cited by 9
Thiazide-Sensitive Cotransporter mRNA Expression Is Not Altered in Three Models of Hypertension
Moreno, G., Bobadilla, N. A., González-Salazar, J. A., Mercado, A., Tapia, E., Hong, E., Herrera-Acosta, J., & Gamba, G. (2001) · Kidney & Blood Pressure Research · doi:10.1159/000054207 · Cited by 7
Impaired Rapid Mineralocorticoid Action on Free Intracellular Calcium in Pseudohypoaldosteronism
Gamarra, F., Ŝimić-Schleicher, G., Huber, R. M., Ulsenheimer, A., Scriba, P. C., Kuhnle, U., & Wehling, M. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.3.3790 · Cited by 7
“The approach chosen here was further supported by results of the molecular analysis of classic type I receptors, whichbyallmeanswerenormalwithregardtotheirprimary structure (13‐15), and by recent results in which a mutation of the sodium channel was found to be essentially involved in the pathogenesis of the autosomal…”
BackgroundResultRossi, E., & Rossi, G. M. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.65187-5 · Cited by 8
Maione, A., Imparato, M., Siciliano, A., Maselli, V., Russo, T., Norcia, M., Guida, M., Lyons, D. M., & Galdiero, E. (2025) · Aquatic Toxicology · doi:10.1016/j.aquatox.2025.107514 · Cited by 6
Efthymiadou, A., Gautschi, I., van Bemmelen, M. X., Sertedaki, A., Giannakopoulos, A., Chrousos, G. P., Schild, L., & Chrysis, D. (2023) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00332.2022 · Cited by 9
Self-citationGenetic factors in hypertension
Padmanabhan, S., Delles, C., & Dominiczak, A. F. (2009) · Cited by 7
Zheng, Q., Wang, Y., Zhao, R., Han, P., Zhao, J., Li, L., Zhou, X., Li, P., Mo, Y., Pan, X., et al. (2023) · Genes & Genomics · doi:10.1007/s13258-023-01376-8 · Cited by 8
“The genetic mutation leads to either loss of function or gain of function, leading to pseudoaldosteropenia type 1 (PHA1) or Liddle’s syndrome, respectively (Chang et al. 1996; Shimkets et al. 1994).”
BackgroundA case of SCNN1A splicing mutation presenting as mild systemic pseudohypoaldosteronism type 1
Ekinci, Z., Aytaç, M. B., & Cheong, H. I. (2013) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2013-0053 · Cited by 7
Freitas, S. R. S. (2017) · American Journal of Hypertension · doi:10.1093/ajh/hpx184 · Cited by 6
Systemic and Pulmonary Hypertension
Marín-García, J. (2007) · Elsevier eBooks · doi:10.1016/b978-012373698-7/50012-7 · Cited by 6
Inactivation of sodium-transporting proteins in the kidney
Rubera, I., Rossier, B. C., & Hümmler, E. (2003) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-002-0951-5 · Cited by 6
“The molecular analysis of patients carrying ENaC mutations has revealed two opposite diseases caused by hypo- and hyperactivity of ENaC, namely pseudohypoaldosteronism (PHA-1), a severe form of salt-losing syndrome (autosomal recessive inheritance) and Liddle’s syndrome, a severe form of saltsensitive hypertension [11…”
BackgroundSelf-citationPseudohypoaldosteronism: kidney, lungs and colon*
Fuller, P. J., & Rogerson, F. M. (2002) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2002.01512.x · Cited by 6
“However, Chang et al. (1996) and Strautnieks et al. (1996) found that the autosomal recessive form was due to mutations in the three (α, β, γ) epithelial sodium-channel subunit genes (ENaC).”
BackgroundGenetic Disorders in Saudi Arabia
Al‐Hassnan, Z. N., & Sakati, N. (2010) · Springer eBooks · doi:10.1007/978-3-642-05080-0_19 · Cited by 8
Ruixo, J. J. P., Porta, B., & Torres, N. (2003) · PubMed · Cited by 6
Clinical Syndromes of Metabolic Acidosis
Krapf, R., Seldin, D. W., Hulter, H. N., & Alpern, R. J. (2008) · Elsevier eBooks · doi:10.1016/b978-0-12-815389-5.00015-0 · Cited by 8
Development of Lung Epithelial Ion Transport: Implications for Neonatal Lung Disease
Pitkänen, O. M., & O'Brodovich, H. M. (1999) · Springer eBooks · doi:10.1007/978-1-4614-7537-8_9 · Cited by 7
Kim, S. J., Park, D., Jang, W., & Lee, J. Y. (2021) · Children · doi:10.3390/children8121090 · Cited by 5
Reverse Phenotypes of Patients with Genetically Confirmed Liddle Syndrome
Granhøj, J., Nøhr, T. K., Hinrichs, G. R., Rasmussen, M. B., & Svenningsen, P. (2024) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.0000000000000430 · Cited by 5
“23,24 There was a clear distinction between the distribution of pseudohypoaldosteronism type 1 and Liddle syndrome variants (Figure 2).”
BackgroundCardiac arrest in a newborn: A case of pseudohypoaldosteronism
Tauber, K. A., Ermacor, K., & Listman, J. A. (2024) · Clinical Case Reports · doi:10.1002/ccr3.8265 · Cited by 5
Mechanisms of epithelial sodium channel (ENaC) regulation by cortactin: Involvement of dynamin
Ilatovskaya, D. V., Pavlov, T. S., Negulyaev, Y. A., & Staruschenko, A. (2012) · Cell and Tissue Biology · doi:10.1134/s1990519x1201004x · Cited by 5
“…that is responsible for partial loss of ENaC function results in pseudohypoaldosteronism type I that is characterized by increased natriuresis (Chang et al., 1996); in contrast, mutation that increases ENaC activity leads to Liddle’s syndrome, a severe form of hypertension (Hansson et al.,…”
BackgroundRenal Modulation: The Renin-Angiotensin-Aldosterone System (RAAS)
Natarajan, A. R., & José, P. A. (2008) · Elsevier eBooks · doi:10.1016/b978-1-4160-3163-5.50013-0 · Cited by 6
Pugh, C. P. (2022) · Cureus · doi:10.7759/cureus.23918 · Cited by 7
Probing the Ubiquitination-Mediated Function of Epithelial Sodium Channel in A549 Cells
Öz, M., Shabbir, W., Yang, K. S., Dogar, A. M., & Isaev, D. S. (2022) · Current Molecular Pharmacology · doi:10.2174/1874467215666220726112002 · Cited by 6
Gao, Z., Sun, J., Cai, C., Gong, X., & Ma, L. (2023) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-3997000000620 · Cited by 5
“Since variant in the SCNN1 gene was firstly reported to cause PHA1 over two decades ago (19), nearly 45 SCNN1 variants have been identified, including nonsense/missense variants, splicing variants, small insertions/deletions, and large deletions (5,16,20).”
BackgroundRenal tubular disorders of electrolyte regulation in children
Devuyst, O., Belge, H., Konrad, M., Jeunemaître, X., & Zennaro, M. (2016) · Zurich Open Repository and Archive (University of Zurich) · doi:10.5167/uzh-121793 · Cited by 8
“Loss-of-function mutations have been found in affected patients being either homozygous – in consanguineous families – or composite heterozygous [479, 480].”
BackgroundSheng, S., Kashlan, O. B., Hallows, K. R., & Kleyman, T. R. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-381462-3.00030-6 · Cited by 6
Hanukoglu, A., & Hanukoglu, I. (2018) · Clinical Endocrinology · doi:10.1111/cen.13730 · Cited by 5
Self-citationKasahara, Y., Sakurai, T., Matsuda, R., Narukawa, M., Yasuoka, A., Mori, N., Watanabe, H., Okabe, T., Kojima, H., Abe, K., et al. (2018) · Bioscience Biotechnology and Biochemistry · doi:10.1080/09168451.2018.1533802 · Cited by 5
“wasting diseases (loss of sodium reabsorption), such as PHA1 (the mutations in hENaC α or β gene cause to suppress the function of hENaC) and neonatal respiratory distress syndrome [16,17].”
BackgroundFundamentals of Ion Transport Across Human Sweat Gland in Health and Disease
Reddy, M. M. (2020) · Physiology in health and disease · doi:10.1007/978-3-030-55310-4_5 · Cited by 6
Yang, T., Song, C., Ralph, D. L., Andrews, P., Sparks, M. A., Koller, B. H., McDonough, A. A., & Coffman, T. M. (2022) · Journal of the American Heart Association · doi:10.1161/jaha.122.026581 · Cited by 5
Erythrocyte Na+,K+‐ATPase and nasal potential in pseudohypoaldosteronism*
Bistritzer, T., Kerem, E., Berkovitch, M., Rapoport, M. J., Evans, S., & Aladjem, M. (2002) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2002.01503.x · Cited by 5
“RESULTS In the twins with PHA1-S, persistently low activity of RBC Na+,K+-ATPase was found during a 6- year follow-up.”
BackgroundInfluentialRenal Ion Channels, Electrophysiology of Transport, and Channelopathies
Stockand, J. D. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-381462-3.00008-2 · Cited by 5
Keavney, B. D., & Lathrop, M. G. (2007) · Cambridge University Press eBooks · doi:10.1017/cbo9780511543555.026 · Cited by 5
Still Building on Candidate-Gene Strategy in Hypertension?
Tesson, F., & Leenen, F. H. H. (2007) · Hypertension · doi:10.1161/hypertensionaha.107.096800 · Cited by 5
Amiloride: the “new” renal tonic?
Warnock, D. G. (2015) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00237.2015 · Cited by 5
“The importance of ENaC in these processes is highlighted by functional mutations, both gain-of-function (Liddle’s syndrome) associated with hypertension (17) and loss-of-function (pseudohypoaldosteronism), which is associated with low blood pressure (5).”
BackgroundSure, F., Einsiedel, J., Gmeiner, P., Duchstein, P., Zahn, D., Korbmacher, C., & Ilyaskin, A. V. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.105785 · Cited by 4
“Conversely, loss-of-function ENaC mutations can result in life-threatening pseudohypoaldosteronism type 1B (PHA1B), with severe hypotension and renal salt wasting (24 – 27).”
Zelikovic, I. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-53367-6.00019-4 · Cited by 4
Pulmonary manifestations of Pseudohypoaldosteronism type 1b: A systematic review of the literature
Chantzaras, A., Panagiotou, P., Koltsida, G., Moudaki, A., Kanaka‐Gantenbein, C., & Kaditis, A. G. (2024) · Paediatric Respiratory Reviews · doi:10.1016/j.prrv.2024.09.001 · Cited by 8
Multifaceted roles of Epac signaling in renal functions
Pochynyuk, O. M., Pyrshev, K. A., & Cheng, X. (2025) · Biochemical Journal · doi:10.1042/bcj20253103 · Cited by 4
Aldosterone Secretion and Action
Fuller, P. J., & Young, M. J. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-18907-1.00101-3 · Cited by 6
A 5-Week-Old Boy with Failure to Thrive, Marked Hyperkalemia, and Hyponatremia
Xu, M., Blasi, C. C. D., Dickerson, J. A., Jack, R. M., & Rutledge, J. C. (2016) · Clinical Chemistry · doi:10.1373/clinchem.2015.252320 · Cited by 4
Rooj, A. K., Cormet‐Boyaka, E., Clark, E. B., Qadri, Y. J., Lee, W., Boddu, R., Agarwal, A., Tambi, R., Uddin, M. J., Parpura, V., et al. (2021) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00298.2020 · Cited by 4
Systemic pseudohypoaldosteronism-1 with episodic dyslipidemia in a Sudanese child
Abdalla, A. T., Alhassan, M., Tawfeeg, R., Sanad, A., Tawamie, H., & Abdullah, M. (2021) · Endocrinology Diabetes and Metabolism Case Reports · doi:10.1530/edm-21-0010 · Cited by 6
Adachi, M., Nagahara, K., Ochi, A., Toyoda, J., Muroya, K., & Mizuno, K. (2022) · Journal of the Endocrine Society · doi:10.1210/jendso/bvac147 · Cited by 4
“Classification based on a molecular basis has been established [4, 5], namely, autosomal dominant PHA1 (PHA1A, alternatively called renal form) and autosomal recessive PHA1 (PHA1B, generalized form).”
BackgroundAlexander, R. T., & Böckenhauer, D. (2023) · Springer eBooks · doi:10.1007/978-3-031-11665-0_39 · Cited by 5
Kostakis, I. D., Cholidou, K. G., & Perrea, D. N. (2012) · HORMONES · doi:10.1007/bf03401536 · Cited by 5
“mutations in promoters or introns of ENaC genes or in other genes.(67,88,91) Finally, it has been suggested that some sporadic cases of either renal or systemic”
Chapter 5 Channelopathies of Transepithelial Transport and Vesicular Function
Hübner, C. A., & Jentsch, T. J. (2008) · Advances in genetics · doi:10.1016/s0065-2660(08)01005-5 · Cited by 5
Inherited Na transport disorders: the taming of the syndromes
Vehaskari, V. M. (2004) · Current Opinion in Pediatrics · doi:10.1097/00008480-200404000-00012 · Cited by 4
Metadata
- Authors
- Chang, S. S., Grunder, S., Hanukoglu, A., Rösler, A., Mathew, P. M., Hanukoglu, I., Schild, L., Lu, Y., Shimkets, R. A., Nelson-Williams, C., Rossier, B. C., & Lifton, R. P.
- Affiliations
- Howard Hughes Medical Institute (US)
- Tel Aviv University (IL)
- Hebrew University of Jerusalem (IL)
- Dhahran Health Center (SA)
- Tel Aviv Sourasky Medical Center (IL)
- University of Lausanne (CH)
- Venue
- Nature Genetics
- Published
- 1996-03
- Volume
- 12
- Issue
- 3
- Pages
- 248-253
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W2059116113
- Cited by
- 808
- References
- 41
- Citations by year
- 2026: 9 · 2025: 13 · 2024: 12 · 2023: 19 · 2022: 13 · 2021: 16 · 2020: 22 · 2019: 15 · 2018: 19 · 2017: 23 · 2016: 27 · 2015: 23 · 2014: 29 · 2013: 25 · 2012: 39
- FWCI
- 14.92
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- IRIS (submittedVersion)
- SERVAL (Université de Lausanne) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion Transport and Channel Regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion channel regulation and function
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Keywords
- pseudohypoaldosteronism type 1, autosomal recessive disorder, epithelial sodium channel, amiloride-sensitive sodium channel, salt wasting, hyperkalemia, metabolic acidosis, consanguinity, homozygous mutation, frameshift mutation, missense mutations, co-segregation
- MeSH terms
- Animals, Base Sequence, DNA, Epithelium, Female, Humans, Infant, Infant, Newborn, Male, Molecular Sequence Data, Mutation, Pedigree, Pseudohypoaldosteronism, Sodium Channels, Rats, Epithelial Sodium Channels
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.